{"id":"https://openalex.org/W68898181","doi":null,"title":"Pharmacokinetics and pharmacodynamics of glipizide in healthy volunteers.","display_name":"Pharmacokinetics and pharmacodynamics of glipizide in healthy volunteers.","publication_year":1983,"publication_date":"1983-02-01","ids":{"openalex":"https://openalex.org/W68898181","mag":"68898181","pmid":"https://pubmed.ncbi.nlm.nih.gov/6341263"},"language":"en","primary_location":{"id":"pmid:6341263","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6341263","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of clinical pharmacology, therapy, and toxicology","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110268576","display_name":"P J Pentik\u00e4inen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P J Pentik\u00e4inen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089475081","display_name":"Pertti J. Neuvonen","orcid":"https://orcid.org/0000-0003-3631-9411","observed_orcids":["https://orcid.org/0000-0003-3631-9411"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P J Neuvonen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"A Penttil\u00e4","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A Penttil\u00e4","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.665,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":{"value":0.65526372,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"21","issue":"2","first_page":"98","last_page":"107"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.8765000104904175,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.8765000104904175,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.05510000139474869,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.023800000548362732,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glipizide","display_name":"glipizide","score":1.0},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9890000224113464},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9940000176429749},{"id":"https://openalex.org/keywords/oral-glucose-tolerance","display_name":"oral glucose tolerance","score":0.5350000262260437},{"id":"https://openalex.org/keywords/insulin-secretion","display_name":"insulin secretion","score":0.7820000052452087},{"id":"https://openalex.org/keywords/glucagon","display_name":"glucagon","score":0.902999997138977},{"id":"https://openalex.org/keywords/plasma-glucose","display_name":"plasma glucose","score":0.8820000290870667},{"id":"https://openalex.org/keywords/first-pass-metabolism","display_name":"first-pass metabolism","score":0.8569999933242798},{"id":"https://openalex.org/keywords/renal-clearance","display_name":"renal clearance","score":0.7889999747276306},{"id":"https://openalex.org/keywords/urine-ph","display_name":"urine pH","score":0.6679999828338623},{"id":"https://openalex.org/keywords/two-compartment-model","display_name":"two-compartment model","score":0.7310000061988831},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.6589999794960022}],"concepts":[{"id":"https://openalex.org/C2779555806","wikidata":"https://www.wikidata.org/wiki/Q3108899","display_name":"Glipizide","level":3,"score":0.9924384355545044},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8482486009597778},{"id":"https://openalex.org/C139254425","wikidata":"https://www.wikidata.org/wiki/Q1332167","display_name":"Volume of distribution","level":3,"score":0.6915591955184937},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5831669569015503},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4945673644542694},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.4663471579551697},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.46134358644485474},{"id":"https://openalex.org/C2780026642","wikidata":"https://www.wikidata.org/wiki/Q40924","display_name":"Urine","level":2,"score":0.43430501222610474},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.41094881296157837},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3425911068916321},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.3284029960632324},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.24660050868988037},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07452243566513062}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005913","descriptor_name":"Glipizide","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005913","descriptor_name":"Glipizide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005934","descriptor_name":"Glucagon","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013453","descriptor_name":"Sulfonylurea Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:6341263","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6341263","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of clinical pharmacology, therapy, and toxicology","raw_type":"Journal Article"},{"id":"mag:68898181","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6341263","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1967973317","https://openalex.org/W1915963975","https://openalex.org/W2062748968","https://openalex.org/W2046388747","https://openalex.org/W2408418991","https://openalex.org/W2022185633","https://openalex.org/W1515153413","https://openalex.org/W1567093432","https://openalex.org/W7098815451","https://openalex.org/W2352649775"],"abstract_inverted_index":{"Single":[0],"doses":[1],"of":[2,29,34,42,48,56,61,74,87,107,114,130,139,170,220,236],"14C-glipizide":[3],"were":[4,101,207,230],"given":[5],"intravenously":[6],"(1":[7],"mg/4.7":[8],"microCi)":[9,14],"and":[10,27,83,99,104,123,228],"orally":[11],"(5":[12],"mg/8.0":[13],"to":[15,23,161],"six":[16],"healthy":[17],"volunteers":[18],"in":[19,37,96,110,176,191,214,238],"a":[20,68,182,210],"crossover":[21],"study":[22],"investigate":[24],"both":[25,120],"pharmacokinetics":[26,60],"effects":[28,224],"glipizide.":[30],"Based":[31],"on":[32,152,156,225],"recoveries":[33],"total":[35,127,163],"14C":[36],"urine":[38],"the":[39,57,75,84,108,157,162,171,177,222,233],"gastrointestinal":[40],"absorption":[41],"glipizide":[43,63,115,131,180,221,237],"was":[44,78,132,143,150,174],"complete.":[45],"The":[46,59,72,112,126],"extent":[47],"first-pass":[49],"metabolism":[50],"averaged":[51,89,117],"4.8":[52],"+/-":[53,80,91,134,145],"0.04%":[54],"(SE)":[55],"dose.":[58],"i.v.":[62,122,172],"could":[64],"be":[65],"described":[66],"by":[67,166,209],"two-compartment":[69],"open":[70],"model.":[71],"volume":[73,86],"central":[76],"compartment":[77],"4.25":[79],"0.25":[81],"l":[82],"steady-state":[85],"distribution":[88],"11.7":[90],"1.1":[92],"l.":[93],"Glipizide":[94],"concentrations":[95,109,235],"red":[97],"cells":[98],"saliva":[100],"only":[102,165],"4%":[103],"1%,":[105],"respectively,":[106],"plasma.":[111,239],"half-life":[113],"elimination":[116],"3.3":[118],"h":[119],"after":[121],"p.o.":[124],"administration.":[125],"plasma":[128,192,215,226],"clearance":[129,149,164],"42.2":[133],"5.4":[135],"ml/min,":[136],"whereas":[137],"that":[138],"protein":[140],"unbound":[141],"fraction":[142],"1350":[144],"130":[146],"ml/min.":[147],"Renal":[148],"dependent":[151],"urinary":[153],"pH,":[154],"but":[155],"average":[158],"it":[159],"contributed":[160],"5%.":[167],"About":[168],"17%":[169],"dose":[173],"found":[175],"feces.":[178],"Intravenous":[179],"caused":[181],"rapid":[183],"increase":[184],"(peak":[185],"at":[186],"6":[187],"min,":[188],"about":[189],"four-fold)":[190],"insulin":[193,227],"lasting":[194],"for":[195],"30":[196],"min.":[197],"Plasma":[198],"glucagon":[199],"showed":[200],"an":[201],"almost":[202],"simultaneous":[203],"decrease.":[204],"These":[205],"responses":[206],"followed":[208],"more":[211],"sustained":[212],"decrease":[213],"glucose.":[216],"After":[217],"oral":[218],"administration":[219],"maximal":[223],"glucose":[229],"seen":[231],"before":[232],"peak":[234]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}